G. Kenneth Lloyd
Chief Tech/Sci/R&D Officer bij BEYONDSPRING INC.
Vermogen: 145 088 $ op 31-03-2024
Profiel
G.
Kenneth Lloyd is the founder of GKOL, Inc. He is currently the Chief Scientific Officer at BeyondSpring, Inc. Dr. Lloyd received his undergraduate and graduate degrees from McGill University and his doctorate from the University of Toronto.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BEYONDSPRING INC.
0.10% | 01-03-2023 | 40 641 ( 0.10% ) | 145 088 $ | 31-03-2024 |
Actieve functies van G. Kenneth Lloyd
| Bedrijven | Functie | Begin |
|---|---|---|
| BEYONDSPRING INC. | Chief Tech/Sci/R&D Officer | 01-06-2015 |
Eerdere bekende functies van G. Kenneth Lloyd
| Bedrijven | Functie | Einde |
|---|---|---|
| Dalian Wanchun Biotechnology Co. Ltd. | Chief Tech/Sci/R&D Officer | 01-01-2014 |
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 29-04-2013 |
A.E. Wyeth & Co.
 A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The private company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Chief Tech/Sci/R&D Officer | - |
| Sanofi SA | Corporate Officer/Principal | - |
Verne Mendel Medical Corp.
 Verne Mendel Medical Corp. Pharmaceuticals: MajorHealth Technology Verne Mendel Medical Corp. develops pharmaceutical product candidates to treat mitochondrial degenerative diseases. Its products include candidates treat neurodegenerative group diseases, such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s; stroke, glaucoma, deafness, and inherited mitochondrial diseases; and metabolic group diseases, including diabetes, and its cardiac and neurologic complications. The company is headquartered in San Diego, CA. | Director/Board Member | - |
Opleiding van G. Kenneth Lloyd
| McGill University | Graduate Degree |
| University of Toronto | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BEYONDSPRING INC. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
| Sibia Neurosciences, Inc. | Health Technology |
A.E. Wyeth & Co.
A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The private company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Commercial Services |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
| Wyeth-Ayerst Research | |
| Sanofi SA | Health Technology |
| GKOL, Inc. | |
Verne Mendel Medical Corp.
Verne Mendel Medical Corp. Pharmaceuticals: MajorHealth Technology Verne Mendel Medical Corp. develops pharmaceutical product candidates to treat mitochondrial degenerative diseases. Its products include candidates treat neurodegenerative group diseases, such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s; stroke, glaucoma, deafness, and inherited mitochondrial diseases; and metabolic group diseases, including diabetes, and its cardiac and neurologic complications. The company is headquartered in San Diego, CA. | Health Technology |
| Dalian Wanchun Biotechnology Co. Ltd. |
